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Previous  studies  on  the  immunology  of  streptococcal  mucopeptidO  in- 
dicate  that  the  peptide moiety isolated by enzymatic means is  a  dominant 
antigenic  determinant  (1).  More recently, it  has  also  been  shown  that  the 
hexosamine polymer may be antigenic (2). In an extension of these observa- 
tions,  immunologic cross-reactions between streptococcal and  staphylococcal 
mucopeptides were noted, but the immunochemical basis for this cross-reac- 
tivity was not defined (3). 
The  mucopeptides  of  streptococci and  staphylococci consist  of  repeating 
units of N-acetylglucosamine and N-acetyl muramic acid. In each case, tetra- 
peptides,  composed of L-alanine,  D-glutamic  acid,  lysine,  and  D-alanine,  are 
linked to the hexosamine polymer through the carboxyl group of the muramic 
acid,  and in turn the tetrapeptides of adjacent hexosamine polymers are co- 
valently cross-linked to form a matrix (4, 5, 6). The cross-link extends from the 
carboxyl group of n-alanine of one tetrapeptide to the free amino group of the 
lysine  of  another  tetrapeptide.  The  major  chemical  difference between  the 
mucopeptides  of  streptococci  and  staphylococci  is  the  composition  of  the 
peptide bridge  spanning  the  tetrapeptides.  The peptide bridge of hemolytic 
streptococci consists of L-alanyl-L-alanine (7), whereas that of staphylococci is 
a peptide of glycine (4). 
Other studies have now directed attention to the antigenic properties of the 
mucopeptides of Staphylococcus  aureus.  Hisatsune et  al.  (8)  isolated  from  a 
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culture filtrate of strain Wiley a  serologically active peptide component which 
had  an amino acid composition similar to  the peptide moiety of mucopeptide. 
The studies  described  here indicate  that  the  immunologic cross-reactivity be- 
tween  the streptococcal  and  staphylococcal mucopeptide  is dependent  in part 
on  the similarity of their tetrapeptides. 
Materials and Methods 
Bazterial Strains.--Streptococcal  strains were obtained from Dr. R. C. Lancefield, Rocke- 
feller University, N. Y.  Staphylococcal strains were from the Department of Microbiology, 
Pennsylvania State University, Pa. 
Preparation of Call Wa//s.--Cell walls were prepared by the method of Bleiweis et al.  (9) 
from:  Group A-variant streptococci, strain T27A Variant; and  S. aureus strains  PSU, S~, 
Sba, and S~4. 
Preparation of Mucopeptide.--Particulate  streptococcal mucopeptide was obtained  as an 
insoluble residue after extraction of cell walls by the hot formamide method of Fuller (10) as 
described by Kranse and McCarty (11).  Particulate  staphylococcal mucopeptides were pre- 
pared  by hot trichloroacetic acid  (TCA)  treatment  of cell walls as described  by Park  and 
Hancock (12). 
Ion Exchange Chromatography.--The amino acids and amino sugars of acid hydrolysates of 
mucopeptide  were  determined  by  ion exchange chromatography  on  a  modified  Beckman- 
Spinco 120 C amino acid analyzer (13). 1 mg samples of mucopeptide were hydrolyzed in 1 ml 
of 6 N HC1 for 5 and 24 hr in an evacuated, deaerated, sealed glass tube. The hydrolysate was 
evaporated to dryness in a rotary evaporator at 40°C, and the residue was dissolved in 3 ml of 
the pH 2.2 buffer used with the amino acid analyzer. The hydrolysate was passed through a 
Millipore faker before addition to the columns.  Analyses were performed on duplicate 5 and 
24 hr hydrolysis samples.  Amino sugar values obtained at 5 and 24 hr were extrapolated to zero 
time.  Complete rdease of amino acids was observed at 24 hr.  During this time, under  the 
conditions of hydrolysis employed here, there was no evident degradation of the major amino 
acids present in the mucopeptide.Therefore, 24 hr hydrolysis values were used to calculate the 
amino acids.  Conversion factors for both amino acids and amino sugars were determined from 
standard mixtures which were analyzed at intervals between analyses of samples. 
Total  nitrogen,  ash,  and  moisture  of  the  mucopeptide  were  performed  by  Mr.  Bella, 
analytical  chemist,  Rockefeller  University. 
Cell Wall Lytio Enzymes.--Partially purified AL-proteinase from a  culture of Myxobacter 
(strain AL-1) was kindly supplied by Dr. R. S. Wolfe, Department of Microbiology, University 
of Illinois. Lysostaphin preparations were supplied through the courtesy of Dr. P. A. Tavor- 
mina, Mead Johnson Research Center, Evansville, Ind. 
Serological Methods.--The preparation of mucopeptide antiserum by rabbit immunization 
with Group A-variant streptococci, and methods for qualitative and quantitative precipitin 
tests  have been  previously described  (1). 
Mucopeptide  which had  been  solubilized  by ultrasonic  treatment  was employed in  the 
precipitin tests.  The mucopeptide,  suspended  in saline, was  cooled  by an  ice bath  during 
treatment for 15 min in a 20 kc sonic oscillator. 
Miorozone Electrophoresis.--Methods  for Microzone electrophoresis of serum proteins and 
isolated immune globulins have been reported  (14). 
Preparative Zone Electrophoresis of Serum.--The supporting medium was 0.5% agarose in 
Veronal buffer 0.05 ax, pH 8.6.  Electrophoresis was carried out for 24 hr at 4°C, 200 v, and 
50 ma. The Agarose block was 25 cm long,  12.5 cm wide, and 0.5 cm deep. 
Protein Determination.--Total  protein in antiserum,  serum fractions, and  isolated muco- 
peptide antibody was determined by the biuret method (15). KARAKAWA~ BRAUN, LACKLAND~ AND  KRAUSE  327 
RESULTS 
Previous studies have directed attention to the immunologic cross-reactivity 
among the mucopeptides of several different Gram-positive bacteria, including 
staphylococci and hemolytic streptococci (3).  Such  an immunologic relation- 
TABLE I 
Chemical Compositions of Streptococcal and Staphylococcal Mmopeptide  Preparations 
Component  Streptococcal mucopeptide  Staphylococcal  mucopeptide 
Glucosamine 
Muramic acid 
Alanine 
Glutamic acid 
Lysine 
Glycine 
Histidine 
Arginine 
Aspartic acid 
Threonine 
Serine 
Proline 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Ammonia 
t*mole/rng 
O. 650 
0.604 
1.576 
O. 767 
0.709 
2.691 
t~mole/mg  #g/mg 
0.728  160.97 
0.622  182.48 
2. 628  234.17 
O. 663  97.62 
0.717  104.84 
0.072  5.38 
0.006  0.98 
0.014  2.38 
O. 025  3.36 
0.013  1.51 
0.010  1.00 
<0.OO5 
0.043  5.06 
0.015  2.20 
0.033  4.29 
0.047  6.22 
0.032  5.74 
0.045  7.49 
14.18 
839.87 
0.021 
0.017 
0.104 
0.067 
O. 101 
<0.005 
O. 102 
0.039 
O. 101 
O. 120 
0.006 
0.059 
~g/m& 
143.78 
177.09 
140.41 
112.89 
103.68 
202.02 
3.30 
2.89 
13.86 
8.04 
10.57 
11.92 
5.83 
13.20 
15.69 
1.08 
9.78 
6.87 
Total recovery..  982.9 
All values are  given in terms  of the anhydrous  ash-free mucopeptide. The lyophilized 
staphylococcal mucopeptide was 7~29% moisture and 8.25% ash. The lyophilized strepto- 
coccal mucopeptide was 3.14% moisture and 2.04% ash. The/~g/mg values for the amino 
sugars have been calculated to include the acetylation of these sugars in the native state. 
The ammonia values were corrected for the amounts of ammonia contributed by decom- 
position of the amino sugars. The amount contributed by degradation of trace amino acids 
such as serine has not been included. 
ship is  consistent with  the  observation that  the  mucopeptides of  these  two 
bacteria have a similar chemical structure. Presented in Table I are the chemical 
compositions of  the  mucopeptides of  Group  A-variant streptococci  and  S. 
aureus, strain PSU. The mucopeptides isolated from both organisms possess the 
same major amino acids although there is a difference in their mole ratios. These 
analytical data are in essential agreement with those previously reported (1, 
4, 11,  16), with the exception that the glycine in the staphylococcal mucopep- 328  STREPTOCOCCAL AND STAPHYLOCOCCAL  MUCOPEPTIDE 
tide is somewhat less than expected. It is conceivable that this variation is due 
to the procedures employed to isolate this substance, or due to variation from 
strain to strain. Nevertheless, the analytical data are consistent with the notion 
that both streptococcal and staphylococcal mucopeptides contain tetrapeptides 
of  L-alanine,  D-glutamic  acid,  lysine,  and  D-alanine  with  a  mole ratio of 
1:1:1:1,  which in the case of streptococci are cross-linked  by L-alanyl-L-ala- 
nine, and in the case of staphylococci by a pepdde of glycine.  The following 
studies on the immunology of streptococcal and staphylococcal mucopeptides 
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FIG. 1. Quantitative precipitin reaction between sonically disrupted mucopeptide of 
Group A-variant streptococci  and S. aureus and Group A-variant carbohydrate, and Group 
A-variant antisera. 
suggest that the antigenic cross-reactivity between these two substances is due 
to  their  similar  tetrapeptides.  In  these  experiments,  the  reaction  between 
mucopeptide antibodies in Group A-variant antisera and staphylococcal muco- 
peptide have been examined in detail. 
Cross-Reaction  between Streptococcal  and  Stapkylococcal  Mucopeptides.--A1- 
though mucopeptide antibodies are produced by rabbits which are immunized 
with particulate mucopeptide which has been isolated from the cell wall,  the 
antibody response is not  as marked  as that  achieved when  rabbits  are im- 
munized intravenously with vaccines prepared with intact  Group A-variant 
streptococci, strain 486. However, such Group A-variant antisera exhibit great 
variability in the relative amount of antibodies to mucopeptide and to Group 
A-variant carbohydrate. Illustrated in Fig. 1 are the results of the quantitative 
precipitin tests which employed Group A-variant  antisera,  and streptococcal KARAKAWA~ BRAUN~ LACKLAND~ AND KRAUSE  329 
and  staphylococcal  mucopeptides  and  Group  A-variant  carbohydrate.  It 
should  be noted that both streptococcal and staphylococcal mucopcptides 
solubilized by ultrasonic treatment  gave  strong  reactions with  antiserum 
R2358, whereas, the Group A-variant carbohydrate gave a minimal reaction. 
The situation was reversed in the case of antiserum R2216. This antiserum had 
a much higher concentration of Group A-variant antibodies than mucopeptide 
antibodies. This reciprocal relationship argues against the possibility that the 
mucopeptide precipitin  reaction is due  to incomplete extraction  of cell wall 
Group A-variant antiserum  /I 
A--Fast 
Absorbed with mucopeptide 
Fast 
L_ 
Antibody eluted from mucopeptide 
Slow 
Fro. 2. Dendtometzic scans  of Microzone electrophoretic  patterns  of Group A-variant 
antiserum R2358 before and after absorption with mucopeptide. Depicted in  the  bottom 
frame is the pattern of the~/G-globulin eluted from the mucopeptide. 
antigens from the mucopeptide, and supports the view that immnni~ation with 
Group A-variant vaccines gives rise to antibodies with A-variant specificity 
and antibodies with mucopeptide specificity. 
Isolation of Mucopeptide Antibodies from  Antiserum.--Mucopeptide anti- 
bodies  were  isolated  from  Group  A-variant  antiserum  by  absorption  onto 
particulate staphylococcal mucopeptide followed by elution at acid pH. 
1 mg of staphylococcal mucopeptide was added to each milliliter of antiserum. After 
storage for 24 hr at 4°C, the particulate mucopeptide was collected by centrifugation and was 
washed three  times with  cold saline. The antibody  was dissociated from the  particulate 
mucopeptide by the addition of saline adjusted to pit 2 with HCL After centrifugation, the 
supernatant  containing the antibody was neutralized with 0.1 M Tris buffer [ttis(hydroxyo 
methyl)aminomethane],  pH 8.0, in 0.5 x NaCI. 330  STREPTOCOCCAL  AND  STAPIIYLOCOCCAL ~IUCOPEPTIDE 
Electrophoretic patterns of unabsorbed serum, serum absorbed  with muco- 
peptide, and antibodies eluted from the mucopeptide  are depicted in Fig.  2. 
The major portion of the slow ~,-globulin component was  absorbed  by the 
mucopeptide. The ~-globnlin recovered from the mucopeptide had a migration 
similar  to this slow component.  The isolated  antibody was identified  as ~G- 
globulin by means of immunoelectrophoresis.  The antibody eluted from the 
mucopeptide did not react with Group A-variant carbohydrate. The antibodies 
to Group A-variant carbohydrate were identified in the fast ^/-globulin peak. 
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FIG. 3.  Preparative  zone  electrophoresis  of  Group  A-Variant  antiserum  R2358.  The 
protein eluted from 0.5 cm segments of the Agarose  block was measured at 280 m#. Only 
protein values are recorded  for segments in the T-globulin region of the block.  The protein 
fractions eluted from the segments were combined into 4 pools (A, B, C,  D)  designated  in 
the figure. 
Because  these absorption studies of this Group A-variant antiserum with 
particulate mucopeptide indicate that the antibodies  to mucopeptide have a 
slower electrophoretic  migration than the Group A-variant antibodies,  it has 
proved feasible to separate these antibodies from each other by means of pre- 
parative zone electrophoresis. 
The protein eluted from 0.5 cm segments of an Agarose block is presented in Fig. 3. Eluates 
were pooled as indicated in the figure, and the pools designated A, B, C, and D. The pools 
were concentrated and dialyzed against 0.1 M Tris buffer, pH 8.0, in 0.5 M NaCI. Depicted in 
Fig. 4 are Microzone electrophoretic  patterns of these pools and the original antiserum. 
Group A-variant antibodies  were detected only in pool D. Pools A  and B 
contained the bulk of the antibodies to mucopeptide.  This is illustrated in the KARAKAWA,  BRAUN,  LACKLAND, AND  KRAUSE  331 
quantitative precipitin curves in Fig. 5. The volume of each pool was adjusted 
by the addition of saline so that the protein content was 8 mg/ml. Pools C and 
D  were appreciably less reactive with staphylococcal mucopeptide than pools 
A and B. 
Isolation of Haptenic Inhibitors from an Enzymatic Digest of Mucopeptide.-- 
The peptide moiety has been identified as an immunodominant group of strepto- 
coccal mucopeptide (1)  and staphylococcal mucopeptide  (8).  Furthermore,  a 
common  feature  between  the  peptide  moieties  of  both  streptococcal  and 
staphylococcal mucopeptides  is  a  tetrapeptide.  It  is  reasonable  to  assume 
FIa.  4.  Microzone  electrophoresis of  Group  A  variant antiserum R2358  and "r-globulin 
pools A,  B,  C,  and  D  recovered from preparative electrophoresis of the serum  as depicted 
in Fig. 3. 
therefore, that the immunologic cross-reactivity of streptococcal and staphylo- 
coccal nmcopeptides is dependent upon this common tetrapeptide. Evidence in 
support of this view was obtained by demonstrating that a peptide moiety of 
staphylococcal  mucopeptide,  isolated  by  enzymatic  means,  inhibited  the 
precipitin  reaction  between  staphylococcal mucopeptides  and  antibodies  to 
streptococcal mucopeptide. 
Various methods were employed to isolate and identify haptenic fractions of 
staphylococcal mucopeptide which had been digested with muralytic enzymes. 
These methods, which include ion exchange chromatography and Sephadex gel 
filtration,  have  been  employed  previously to  isolate  the  haptenic  peptide 
moiety of streptococcal mucopeptide (1). 
The  two  lytic  enzyme  preparations  which  were  employed  to  digest the 
staphylococcal  mucopeptide  were  AL-proteinase,  derived  from  Myxobacter 
strain AL-1, and lysostaphin. Recent studies have shown that AL-proteinase 332  STREPTOCOCCAL AND  STAPHYLOCOCCAL MUCOPEPTIDE 
preparations  contain  activities which  hydrolyze  N-acetyl muramyl-L-alanine, 
D-alanyl-glycine, and glycyl-glycine (17).  The  lysostaphin  preparation  has  the 
enzyme specificities similar  to AL-proteinase,  with  the  exception  that  it lacks 
the  capacity  to  split  D-alanyl-glycine  (18,  19).  But,  in  addition  lysostaphin 
hydrolyses  the glycosidic bonds  in  the hexosamine  polymer. 
100 mg of staphylococcal mucopeptide was suspended  in 25 ml of Tri~ buffer,  pH 9.  10 
mg of AL-proteinase were added  to  the  suspension  and  the mixture incubated  at 37°C  for 
24 hr according to the method of Ensign and Wolfe (20). The digest was dialysed in cellophane 
tubing against frequent changes of distilled water, and the dialysates were pooled, concentrated, 
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Fit;.  5.  Quantitative  precipitin  reaction  between  sonically  disrupted  staphylococcal 
mucopeptide and the 7-globulin pools A, B,  C, and D  recovered from preparative  electro- 
phoresis of serum R2358  as depicted in Fig. 3. The protein content of each pool was adjusted 
to 8 mg/ml and 0.1 ml was employed in the precipitin tests. 
and lyophilized. The lyophilized product was resuspended in 0.02 ~  (NH4)2CO3, pH 8.6, and 
separated on a  DEAE-cellulose column equilibrated and eluted with this buffer.  Three frac- 
tions, designated I, II, and III, were collected from the DEAE-cellulose column as depicted 
in Fig. 6 a.  Fraction I  was only present in trace amounts and was discarded.  Fractions II 
and  III inhibited  the mucopeptide precipitin reaction.  Fraction II was further  resolved by 
G15-Sephadex  gel  filtration  as  previously  described  (1).  A  fall-through  fraction  strongly 
inhibited the mucopeptide precipitin reaction. A second  fraction, which was retarded by the 
column, was much less inhibitory. The fall-through fraction was labeled IIa and the retarded 
fraction  lib.  They were lyophilized to remove carbonate  buffer  and  saved  for  subsequent 
chemical and immunologic analysis. 
Similar procedures were employed to isolate haptenic fractions from staphylococcal muco- 
peptide which was digested with lysostaphin by the method of Sehind|er and Schuhardt  (18). 
The dialyzable material from 100 mg of a lysostaphin digest of staphyloccal mucopeptide was 
fractionated  on a  DEAE-cellulose column equilibrated and  eluted with  0.02  ~  (NH~)2CO~ 
buffer,  pH 8.6.  In this case,  as depicted in Fig. 6 b,  three major fractions designated I, II. 
and III were obtained.  Fraction I, which represented the fall-through peak, possessed  much 
less inhibitory activity than fraction II and III. Preliminary chemical analysis indicated that KARAKAWA,  BRAUN~ LACKLAND~ AND  KRAUSE  333 
fraction I  was rich in hexosamines and fraction II was composed almost entirely of amino 
acids. Because fraction II contained both hexosamines and amino acids further resolution was 
not attempted. Fraction I  was the source material for isolating the hexosamine moiety and 
fraction III the source material for isolating a haptenic peptide. These fractions were further 
purified by G  15-Sephadex  gel  filtration  as  described above.  In  both cases,  only  the fall- 
through material was collected for subsequent chemical and serologic analysis. The lyophilized 
products were labeled fraction I  and fraction III. 
Presented  in  Table  II  are  the  chemical  analyses  of  the  purified  haptenic 
fractions isolated by DEAE-cellulose  chromatography  from the AL-proteinase 
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FIO.  6  a.  OEAE-cellulose column chromatography of the dialyzable material of the AL- 
proteinase digest of staphylococcal mucopeptide. Column dimensions 300 X  25 mm. Buffer: 
0,02 ~  (NH4)~CO3, pH 8.6 at 4°C. Eluted material was pooled as designated in the figure into 
fractions I, II, and III. 
FIo.  6  b.  DEAE-cellulose chromatography performed as described above in the dialyzable 
material of a  lysostaphin digest of  staphylococcal mucopeptide.  Eluted material was pooled 
as designated in the figure into fractions I,  II,  and III. 334  STREPTOCOCCAL  AND  STAPHYLOCOCCAL  MUCOPEPTIDE 
digest and the lysostaphin digest of staphylococcal mucopeptide. The analysis 
of mucopeptide has been included for comparison.  The AL-proteinase digest 
yielded a glycine-rich fraction as well as a peptide fraction. Fraction IIa con- 
tained  the  amino  acids  of the  tetrapeptide and  a  portion of the polyglycine 
bridge. Fraction IIb was predominantly glycine, presumably derived from the 
polyglycine bridge. Similar split products have been isolated by others (17,  19). 
The components of interest  isolated  from the  lysostaphin  digest  included  a 
hexosamine-rich fraction and a peptide moiety. Fraction I was primarily derived 
TABLE  II 
Chemical  Compositionx of Dialyzable Fractions of Staphylococcal  Mucopeptide Released  by Either 
A L-Protelnase or Lysostaphin 
Components  Mucopeptide 
t~mole/mg 
Glucosamine  0. 650 
Muramic acid  0. 604 
Alanine  1. 576 
Glutamic acid  0. 767 
Lysine  0. 709 
Glycine  2.691 
Recovery, ~;~  .......................... 
AL-proteinase extract  i 
I 
Fraction IIa  Fraction IIb 
1. 635  0.380 
1. 176  0.226 
1. 035  0. 163 
4. 967  7. 706 
84.3  66.9 
Lysostaphin extract 
Fraction I  Fraction III 
1. 765  * 
1.821  * 
0.216  2.309 
0.090  1.214 
0. 106  1. 303 
0.232  3.260 
97.2  82.0 
*, trace amount. 
For the sake of brevity, all amino acid values for enzyme digest fractions which were 0.1 
/zmole/mg or less are not presented in the table. The values are calculated on the basis of the 
lyophilized weight of the sample, and not on the ash-free dry weight. 
from the hexosamine polymer. Fraction III is similar to the peptide fraction IIa 
isolated from the AL-proteinase digest. The recovery of dialyzable hexosamine 
material in fraction I is due to the lysozyme-like activity of lysostaphin. It is to 
be noted, however, that no such material was liberated from mucopeptide by 
the action of AL-proteinase. 
Illustrated in Fig. 7 are the results of inhibition of the mucopeptide precipitin 
reaction with the fractions isolated from the enzymatic digests of staphylococcal 
mucopeptide. The reactions were carried out at antigen-antibody equivalence. 
4 mg/ml of the peptide moiety from the lysostaphin digest fraction III inhibited 
62%  of  the  reaction between  staphylococcal mucopeptide  and  streptococcal 
antiserum. Although not shown in Fig. 7, it should be mentioned parenthetically 
that the peptide moiety from AL-proteinase fraction IIa was an equally good 
inhibitor. On the other hand,  the glycine-rich moiety (AL-proteinase fraction 
IIb)  and the hexosamine-rich moiety (lysostaphin digest fraction I) were Less KARAKAWA, BRAUN,  LACKLAND~ AND  KRAUSE  335 
effective inhibitors.  The inhibition achieved with the hexosamine-rich fraction 
does merit additional comment, however. This suggests that the antiserum also 
contains antibodies  directed against the hexosamine polymer of the mucopep- 
tide. Such a finding is consistent with results reported earlier (2). While experi- 
ence with these inhibition studies is still limited, the picture which is emerging 
is that the peptide moiety is the primary determinant of mucopeptide,  and the 
hexosamine polymer is a secondary determinant. 
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FzG. 7.  Inhibition of the quantitative mucopeptide precipitin reaction with: hexosamine- 
rich fraction I, and peptide-moiety fraction III isolated from the lysostaphin digest of muco- 
peptide; and glycine-rich peptide fraction IIb isolated from AL-proteinase digest of muco- 
peptide. Recovery of these fractions is depicted in Fig. 6. 
Further evidence for the immunologic cross-reactivity  of the mucopeptides of 
streptococci  and staphylococci  was obtained in studies which  employed the 
peptide  isolated  from a  Streptomyces albus enzymes  digest of  streptococcal 
mucopeptide (1), In a final volume of 1 ml, 4 mg were added to a precipitin  re- 
action consisting of 150/~g of solubilized staphylococcal  mucopeptide and 0.1 
ml of streptococcal  antiserum. In comparison  with the control,  precipitation 
was inhibited by 62 %. 
One possible interpretation of these results is that the streptococcal antiserum 
contains one population of antibodies which reacts with the streptococcal muco- 
peptide and another which reacts with staphylococcal mucopeptide.  In a final 
series of experiments,  it was shown that the serum contained antibody which 
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had been recovered from the antiserum by absorption onto particulate strepto- 
coccal mucopepfide and subsequently recovered as described in an earlier sec- 
tion.  Such antibody reacted with the heterologous staphylococcal mucopeptide. 
Furthermore, the reaction was inhibited by 65 % with the peptide (fraction III) 
isolated from the lysostaphin digest of staphylococcal mucopepfide. 
It did not prove feasible by enzymatic means to isolate from mucopeptide a 
tetrapeptide which was devoid of glycine. Nevertheless, the capacity of the 
peptide moiety to inhibit streptococcal and staphylococcal mucopeptide pre- 
TABLE III 
Inhibition  of Staphylococcal Mucopeptide Precipitin  Reactio~  by Synthetic  Peptides 
Inhlbitors  Inhibition 
10 rag/ml 
Glycyl-L-glutamic  acid 
DL-alanine 
L-alanyl-L-alanine 
Poly DL-alanine 
L-alanyl-L-lysine 
L-alanyl-glycyl-glycine 
L-alanyl-L-alanyl-L-alauin  e 
L-alanyl-L-glutamic  acid 
% 
12.4 
3.4 
10.0 
9.7 
10.0 
12.4 
18.4 
34.4 
All precipitin reactions were carried out with 0.1 ml of antiserum and 150 #g of solubilized 
mucopeptide in a final volume  of i ml. Per cent inhibition values were obtained by comparison 
of the amount of antibody recovered in the inhibited reactions to that recovered in a non- 
inhibited reaction. 
cipitin reactions is probably dependent upon the tetrapeptide portion. This is 
supported by the fact that only the tetrapeptide and not the glycine bridge is 
common to both streptococcal and staphylococcal mucopeptide. 
Because the peptide moiety was an effective inhibitor of the  mucopeptide 
precipitin reaction, synthetic peptides were employed in a similar fashion. The 
results are presented in Table III. Inhibition was most prominent with L-alanyl- 
L-glutamic acid. These data are in agreement with the view that the tetrapep- 
tide of mucopeptide is an antigenic determinant. 
DISCUSSION 
Recent evidence from a number of sources indicates that the bacterial muco- 
peptides are potentially antigenic (1, 3, 8, 21, 22). This is not, however, a wholly 
unexpected  development.  Basically,  mucopeptide  consists  of  a  hexosamine 
polymer with peptide side chains linked to the polymer through the carboxyl 
group of the muramic acid residues. Each of these two major components is a 
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bodies to both the hexosamine polymer and the peptide moiety may be de- 
tected in the sera of rabbits after immunization with Group A-variant strepto- 
cocci (1, 2). 
It is,  at present,  a mystery why rabbits immunized with Group A-variant 
streptococci  (23)  are  more  likely  to  produce  mucopeptide  antibodies  than 
rabbits immunized with Groups A or C streptococci (24). One possible explana- 
tion may stem from antigenic competition between the group-specific  carbohy- 
drate and the mucopeptide. The majority of rabbits immunized with Groups A 
and C streptococci usually produce 3--15 mg/ml of antibodies to group carbo- 
hydrate. In some cases, over 80 % of the total ~,-globulin in immune sera may be 
antibody to the carbohydrate antigen.  On the other hand, the Group A-variant 
carbohydrate appears to be a poor antigen.  Many Group A-variant  antisera 
contain less than  1 mg/ml of group-specific  antibody. In the face of a feeble 
response to carbohydrate antigen, the mucopeptide may initiate a more vigor- 
ous immune response. 
Variability in the immune response to mucopeptide may be in part geneti- 
cally determined.  Genetic factors which control the immune response to syn- 
thetic antigens have now been well established in the case of mice and guinea 
pigs. Pinchuck and Maurer have shown that the ability of mice to form anti- 
bodies against  the  random  terpolymer  glu571ys3sala5 is  controlled  by  a  co- 
dominant  Mendelian factor (25).  In guinea pigs,  it has been shown that  the 
ability of poly L-lysine  tO  act  as a  hapten  carrier  for the  2,4-dinitrophenyl 
(DNP) group is transmitted as a simple Mendelian determinant (26, 27, 28, 29). 
Breeding studies with rabbits currently underway may identify genetic factors 
which control a vigorous immune response to mucopeptide. 
In  the  studies  reported  here,  the  immunologic  cross-reactivity  between 
streptococcal and staphylococcal mucopeptide has been studied in detail. The 
evidence suggests that  this cross-reactivity is dependent in large part on the 
fact that a chemically similar  tetrapeptide is a common antigenic determinant 
of both mucopeptides.  It should be stressed,  however, that  the hexosamine 
polymer is also a  common feature of both mucopeptides.  Presumably cross- 
reactivity  can  depend  secondarily  upon  this  common  hexosamine  polymer. 
Precipitin  inhibition  was  achieved  by a  dialyzable  hexosamine-rich  moiety 
isolated from a lysostaphin digest of staphylococcal mucopeptide. Such a result 
is indicative that the hexosamine polymer of staphylococcal mucopeptide has 
antigenic properties similar  to the hexosamine polymer of streptococcal muco- 
peptide (2). 
The  antigenicity  of the tetrapeptide  of mucopeptide is reminiscent  of the 
studies of Fuchs and Sela on the locus of the immunologically important area 
of a multichained polymer of amino acids (30). For example, a polymer which 
was nonantigenic remained so after the addition of peptide side chains consist- 
ing of only a single amino acid. On the other hand, synthetic multichained poly- 338  STREPTOCOCCAL  AND  STAPHYLOCOCCAL  MUCOPEPTIDE 
alanine was converted to an immunogenic substance if the side chain peptides 
contained glu-lys, glu-phe, glu-his, or glu-leu. 
In view of the similarity in chemical composition and structure among the 
bacterial mucopeptides, it will not be surprising if future studies reveal wide- 
spread  immunologic cross-reactivity.  Furthermore,  the  occurrence  of  muco- 
peptides in all bacteria insures prolonged and continuous exposure of animals 
and man to these substances and provides a means for the natural acquisition 
of sensitivity to mucopeptide. It is conceivable that the immune response to 
this family of polymers may play a  role in bacterial allergy. Under these cir- 
cumstances the biological significance of mucopeptide immunity merits atten- 
tion. 
At least two different laboratories have now quite independently directed 
attention to the toxic properties of mucopeptide. Rotta and coworkers have 
shown that the streptococcal cell wall mucopeptide will induce fever in rabbits, 
enhance  nonspecific  resistance  in  mice  against  subsequent  challenge  with 
streptococci, and prepare and provoke the localized Shwartzman phenomenon 
(31). 2 Abdulla and Schwab have observed dermal necrosis following injection of 
mucopeptide into the skin of rabbits (32). Schwab and coworkers have produced 
intermittent subcutaneous nodular lesions after injections of streptococcal cell 
wall particles into the skin of rabbits  (33).  It is their view that mucopeptide 
may be an essential component of the cell wall particles which induce these 
lesions (32). These various biological properties of mucopeptide may be depend- 
ent upon its inherent toxicity, but it is also possible that these toxic reactions to 
mucopeptide after injection by various routes are manifestations of previously 
acquired immunity to mucopeptide. 
SUMMARY 
Particulate mucopeptides  of Group  A-variant  streptococci and Staphylo- 
coccus aureus, solubilized  by ultrasonic treatment, give a precipitin reaction 
with the sera of rabbits immunized with Group A-variant streptococci. 3'-G 
globulin antibodies have been recovered from these sera  which react with the 
mucopeptides but not with the Group A-variant carbohydrate. 
The immunochemical  basis for  the  cross-reactivity  between the  streptococcal 
and staphylococcal mucopeptides was investigated in detail.  Three chemically 
different  fractions  have been isolated  from enzymatic digests  of staphylococcal 
mucopeptide  and were employed  as haptenic inhibitors of the precipitin re- 
action. A  fraction consisting of the peptide moiety of mucopeptide  was  the 
strongest inhibitor, whereas the hexosamine-rich  fraction was less effective. 
The third fraction,  rich in glycine,  was least  effective. 
It is suggested that the immunologic cross-reactivity  between streptococcal 
2  Rotta, J., and B. Bednar. Personal communication. KARAKAWA, BRAUN~ LACKLAND, AND KRAUSE  339 
and staphylococcal mucopeptide is due to the fact that these two substances 
contain  chemically  similar  tetrapeptides.  The  hexosamine  polymer which is 
identical for both mucopeptides may also contribute to their cross-reactivity. 
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